Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
CMOs showed an increasing reluctance to take on debt in 2022
Chinook Therapeutics is a clinical-stage biopharmaceutical company with two high-value, late-stage assets in development for IgA nephropathy (IgAN), a rare, progressive chronic kidney disease
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The appointment is effective from May 01, 2023 for five years
Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Subscribe To Our Newsletter & Stay Updated
